US4194010AExpiredUtility
Pharmacologically active enol ether compounds
Est. expiryOct 29, 1995(expired)· nominal 20-yr term from priority
Inventors:Alexander C. Goudie
C07D 317/20C07C 43/215C07C 43/315
46
PatentIndex Score
1
Cited by
5
References
12
Claims
Abstract
Acetals, enol acylates and enol ethers of the compound of the compound of the formula (I): ##STR1## notionally derivable from a C 1-8 alcohol or C 1-8 acid are useful anti-inflammatory agents.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. An enol ether of the formula (II) or (III): ##STR5## in each of which formulas R 1 is alkyl of 2-4 carbon atoms.
2. An enol ether of claim 1 of the formula (II): ##STR6## in which R 1 is alkyl of 2-4 carbon atoms.
3. An enol ether of claim 1 of the formula (III): ##STR7## in which R 1 is alkyl of 2-4 carbon atoms.
4. An enol ether according to claim 1 in which R 1 is ethyl or propyl.
5. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 1 in combination with a pharmaceutically acceptable carrier.
6. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 2 in combination with a pharmaceutically acceptable carrier.
7. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 3 in combination with a pharmaceutically acceptable carrier.
8. A pharmaceutical composition for treating inflammation which comprises an anti-inflammatory amount of an enol ether of claim 4 in combination with a pharmaceutically acceptable carrier.
9. A pharmaceutical composition according to claim 5 in oral unit dosage form.
10. A method of treating inflammation which comprises administering an anti-inflammatory amount of a composition of claim 5.
11. A method according to claim 10 in which the administration is oral.
12. A method according to claim 10 in which the administration is oral and the composition is in unit dosage form.Join the waitlist — get patent alerts
Track US4194010A — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.